A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes

ClinicalTrials.gov ID: NCT02208011

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02208011. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 5:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart review after delivery. Inclusion Criteria: * English speaking * pregnant woman \>15 weeks gestation undergoing an exam for ruptured membranes Exclusion Criteria: * Known placental previa * Active vaginal bleeding

Study identification

NCT ID: NCT02208011
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Louisiana State University, Baton Rouge; Other
Enrollment: 140 participants

Conditions and interventions

Conditions

Evidence of Ruptured Membranes in Women Greater Than 15 Weekd

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2014 (Type not available)
Primary completion: Jun 2015 (Actual)
Completion: Jun 2015 (Actual)
Last update posted: Sep 2, 2020

2014 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Woman's Hospital	Baton Rouge	Louisiana	70817	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02208011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 2, 2020 · Synced Nov 13, 2026